Zobrazeno 1 - 10
of 35
pro vyhledávání: '"E. Kelland"'
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 8, Iss C, Pp 41-42 (2016)
Externí odkaz:
https://doaj.org/article/0ca7f2d6e6a246eb8bdb4acc0d8e3fcd
Autor:
Kirstine Skov, Jez Wardman, Matthew Healey, Amy McBride, Tzara Bierowiec, Julia Cooper, Ifeoma Edeh, Dave George, Mike E. Kelland, Jim Mann, David Manning, Melissa J. Murphy, Ryan Pape, Yit A. Teh, Will Turner, Peter Wade, Xinran Liu
Publikováno v:
PLoS ONE, Vol 19, Iss 3 (2024)
Externí odkaz:
https://doaj.org/article/c2bff52ba81d4448949da7ce1709dc70
Autor:
Wendy Gilmore, Brett T. Lund, Peili Li, Alex M. Levy, Eve E. Kelland, Omid Akbari, Susan Groshen, Steven Yong Cen, Daniel Pelletier, Leslie P. Weiner, Adil Javed, Jeffrey E. Dunn, Anthony L. Traboulsee
Publikováno v:
Journal of Neuroinflammation, Vol 17, Iss 1, Pp 1-21 (2020)
Abstract Objective To characterize long-term repopulation of peripheral immune cells following alemtuzumab-induced lymphopenia in relapsing-remitting MS (RRMS), with a focus on regulatory cell types, and to explore associations with clinical outcome
Externí odkaz:
https://doaj.org/article/c28fbcdbfa904b3d9f37eeae73f6397e
Autor:
Nicole Kashani, Eve E. Kelland, Borna Vajdi, Lauren M. Anderson, Wendy Gilmore, Brett T. Lund
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Alemtuzumab is a highly effective treatment for relapsing-remitting multiple sclerosis. It selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. We previously s
Externí odkaz:
https://doaj.org/article/a32c0f44f3e54f28a23b32a143d06001
Autor:
Sun young Kim, Eve E. Kelland, Ji hong Kim, Brett T. Lund, Xiao Chang, Kai Wang, Leslie P. Weiner
Publikováno v:
Biochemistry and Biophysics Reports, Vol 9, Iss C, Pp 166-172 (2017)
Retinoic acid (RA), a metabolite of vitamin A, has been found to influence regeneration in the adult central nervous system (CNS). There may be an effect of RA in the recovery/repair in multiple sclerosis (MS), an autoimmune and neurodegenerative dis
Externí odkaz:
https://doaj.org/article/81d7c1f49a3e4637b10190253cbc2cc4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eve E. Kelland, Roslynn Stone, Erika Amundson, S. Lee, Kathleen E. Rodgers, Nicole Kashani, Brett T. Lund, Alexander M Levy
Publikováno v:
Neurobiology of Disease, Vol 127, Iss, Pp 87-100 (2019)
Multiple Sclerosis (MS) is a chronic disease of the central nervous system (CNS) characterized by autoimmune and neurodegenerative pathologies for which there is no cure and no defined etiology. Although several, modestly effective, disease modifying
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Alemtuzumab is a highly effective treatment for relapsing-remitting multiple sclerosis. It selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. We previously s
Autor:
Frank E. Kelland
Publikováno v:
Classical Journal. 115:126-128
Autor:
Ji-Hong Kim, Kai Wang, Leslie P. Weiner, Brett T. Lund, Eve E. Kelland, Sun Young Kim, Xiao Chang
Publikováno v:
Biochemistry and Biophysics Reports
Biochemistry and Biophysics Reports, Vol 9, Iss C, Pp 166-172 (2017)
Biochemistry and Biophysics Reports, Vol 9, Iss C, Pp 166-172 (2017)
Retinoic acid (RA), a metabolite of vitamin A, has been found to influence regeneration in the adult central nervous system (CNS). There may be an effect of RA in the recovery/repair in multiple sclerosis (MS), an autoimmune and neurodegenerative dis